Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004049789 | SCV002622040 | uncertain significance | not specified | 2020-11-02 | criteria provided, single submitter | clinical testing | The p.Q1245* variant (also known as c.3733C>T), located in coding exon 7 of the MLH3 gene, results from a C to T substitution at nucleotide position 3733. This changes the amino acid from a glutamine to a stop codon within coding exon 7. This alteration is expected to result in premature protein truncation or nonsense-mediated mRNA decay. However, the gene-disease association for MLH3 is limited. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005008540 | SCV005635755 | uncertain significance | Endometrial carcinoma; Colorectal cancer, hereditary nonpolyposis, type 7; Colorectal cancer | 2024-06-18 | criteria provided, single submitter | clinical testing |